Skip to main content
Premium Trial:

Request an Annual Quote

Wipro Restructures to Broaden Healthcare and Life Sciences Offerings

Premium

Citing a market opportunity of around $25 billion, growing at over 20 percent annually, Bangalore, India-based IT firm Wipro Limited has created a new segment to focus on healthcare and life science. The company appointed D. A. Prasanna, currently vice chairman of Wipro, to head up the new unit.

Wipro Healthcare and Life Science has a broad mandate, ranging from the development of bioinformatics tools and other discovery informatics, to new technology for electronic FDA submissions, to IT solutions for hospitals and health insurance companies.

Prasanna is also on the board of Wipro GE Medical Systems Limited, a joint venture between Wipro and GE that makes up the bulk of the company’s current activity in the life sciences market. The new segment will comprise the Wipro Healthcare vertical, with customers in hospitals and health insurance companies, along with Wipro Biomed, which currently addresses the IT needs of manufacturers of medical and life science devices.

Wipro spokesman Vijay Gupta explained, “Currently we are an IT company going to healthcare. Wipro Healthcare and Life Science is a healthcare team going with IT solutions.”

Custom bioinformatics solutions will be developed for Wipro customers, Gupta said, but specific details on the technology planned for this purpose were not available.

Gupta noted that “a significant portion” of Wipro’s future total business is expected to come from the HLS group.

— BT

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.